Publications

Year of Publicationsort descending Title Faculty Association
2015 The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D.
2015 Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6. George Watts, Ph.D.
2015 Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2015 Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels. Rajesh Khanna
2015 Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors. Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD
2015 The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. John M. Streicher, PhD
2015 Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Roberta Diaz Brinton, Ph.D
2015 Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Frank Porreca, PhD, Todd Vanderah, PhD
2015 Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Roberta Diaz Brinton, Ph.D
2015 CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Rajesh Khanna
2015 Use of Animal Models in Understanding Cancer-induced Bone Pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2015 Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. Roberta Diaz Brinton, Ph.D
2016 Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. Yeon Sun Lee, Frank Porreca, PhD, Yanhua Xie, Ph.D.
2016 The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD
2016 Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. Nam Lee, Ph.D.
2016 Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2016 Dynorphin A analogs for the treatment of chronic neuropathic pain. Yeon Sun Lee
2016 Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Yeon Sun Lee, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD
2016 Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. Yeon Sun Lee, Frank Porreca, PhD
2016 Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2016 Age, APOE and sex: Triad of risk of Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2016 Cyclic Opioid Peptides. Yeon Sun Lee
2016 Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. Roberta Diaz Brinton, Ph.D
2016 Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. Jeffrey J. Lochhead, PhD
2016 (S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Rajesh Khanna, May Khanna, PhD, Amol Patwardhan, M.D., Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Yanhua Xie, Ph.D.

Pages